Use of cyclosporine in children and adolescents with moderate to severe atopic dermatitis: clinical experience in a tertiary Hospital

被引:0
|
作者
Proenca, Carolina Contin [1 ]
Mayor, Silvia Assumpcao Soutto [1 ]
Ragazzo, Thais Storni [1 ]
Munhoz, Sandy Daniele Germano [1 ]
Pires, Carolina Gadelha [1 ]
机构
[1] Dermatol Clin, Santa Casa Sao Paulo, Sao Paulo, SP, Brazil
关键词
D O I
10.1016/j.abd.2022.10.006
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:526 / 528
页数:3
相关论文
共 50 条
  • [41] Severe Atopic Dermatitis in Children
    Evie Huang
    Peck Y. Ong
    Current Allergy and Asthma Reports, 2018, 18
  • [42] Severe atopic dermatitis in children
    Kudryavtseva, A.
    ALLERGY, 2009, 64 : 279 - 279
  • [43] Clinical profile of children with moderate-to-severe eosinophilia presenting to a tertiary hospital in Nepal
    Shrestha, Shrijana
    Timila, Dipsal
    Karki, Utkarsh
    Shrestha, Ashis
    Bhandary, Shital
    TROPICAL DOCTOR, 2012, 42 (04) : 232 - 234
  • [44] Severe atopic dermatitis in children
    Guerrero, D.
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2006, 46 : S3 - S5
  • [45] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Gold, Linda Stein
    Thaci, Diamant
    Thyssen, Jacob P.
    Gooderham, Melinda
    Laquer, Vivian
    Moore, Angela
    Natalie, Chitra R.
    Zhao, Fangyi
    Meskimen, Eric
    Elmaraghy, Hany
    Montmayeur, Sonia
    Gallo, Gaia
    Jimenez, Gemma
    de Bruin-Weller, Marjolein
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 595 - 607
  • [46] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial program
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Bangert, Christine
    Irvine, Alan D.
    Weidinger, Stephan
    Nesnas, John
    Koppensteiner, Herwig
    Zhang, Fan
    Rojo, Ricardo
    Chan, Gary
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [47] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial programme
    Eichenfield, L. F.
    Flohr, C.
    Bangert, C.
    Irvine, A. D.
    Weidinger, S.
    Nesnas, J.
    Koppensteiner, H.
    Zhang, F.
    Rojo, R.
    Chan, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E142 - E143
  • [48] Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
    Simpson, Eric L.
    Paller, Amy S.
    Siegfried, Elaine C.
    Boguniewicz, Mark
    Sher, Lawrence
    Gooderham, Melinda J.
    Beck, Lisa A.
    Guttman-Yassky, Emma
    Pariser, David
    Blauvelt, Andrew
    Weisman, Jamie
    Lockshin, Benjamin
    Hultsch, Thomas
    Zhang, Qin
    Kamal, Mohamed A.
    Davis, John D.
    Akinlade, Bolanle
    Staudinger, Heribert
    Hamilton, Jennifer D.
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    Eckert, Laurent
    Stahl, Neil
    Yancopoulos, George D.
    Ruddy, Marcella
    Bansal, Ashish
    JAMA DERMATOLOGY, 2020, 156 (01) : 44 - 56
  • [49] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
    Sroka-Tomaszewska, Jowita
    Bulinska, Barabara
    Wilkowska, Aleksandra
    Nowicki, Roman J.
    Trzeciak, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752
  • [50] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Linda Stein Gold
    Diamant Thaçi
    Jacob P. Thyssen
    Melinda Gooderham
    Vivian Laquer
    Angela Moore
    Chitra R. Natalie
    Fangyi Zhao
    Eric Meskimen
    Hany Elmaraghy
    Sonia Montmayeur
    Gaia Gallo
    Gemma Jimenez
    Marjolein de Bruin-Weller
    American Journal of Clinical Dermatology, 2023, 24 : 595 - 607